Area of research
Pulmonary and Respiratory Medicine · Critical Care and Intensive Care Medicine
Research interest
Research interests include Respiratory Support and Mechanisms, Sepsis Diagnosis and Treatment, Intensive Care Unit Cognitive Disorders, and Neonatal Respiratory Health Research.
Prediction of lung overdistension during mechanical ventilation using micro-RNA and gene expression
Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes
Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
The effects of blood cell salvage on transfusion requirements after decannulation from veno-venous extracorporeal membrane oxygenation: an emulated trial analysis
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
A New Global Definition of Acute Respiratory Distress Syndrome
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial
Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials
Advancing specificity in delirium: The delirium subtyping initiative
Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)
Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19
Redefining critical illness
Whole-genome sequencing reveals host factors underlying critical COVID-19
Towards a biological definition of ARDS: are treatable traits the solution?
Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure
Major differences in ICU admissions during the first and second COVID-19 wave in Germany
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Promises and challenges of personalized medicine to guide ARDS therapy
Comparison of machine learning clustering algorithms for detecting heterogeneity of treatment effect in acute respiratory distress syndrome: A secondary analysis of three randomised controlled trials
RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trial
COVID-19: consider cytokine storm syndromes and immunosuppression
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study
Subphenotypes in critical care: translation into clinical practice